Organised by the Cancer Science Institute of Singapore, the Hepatocellular Carcinoma Symposium was held at the Centre for Life Science (CeLS) at the National University of Singapore on 27 August 2014.
Featuring a line-up of distinguished liver cancer experts across various organisations such as CSI Singapore, National Cancer Centre Singapore (NCCS), Genome Institute of Singapore (GIS), National University Hospital and Duke-NUS Graduate Medical School, the symsposium kicked off with a one-hour keynote speech from internationally-renowned scientist Dr Scott W. Lowe.
Dr Lowe, whose lab focuses on tumour-supressor networks controlling apoptosis and senescence and how their distruption influences malignant behaviour, is currently Chair of the Cancer Biology and Genetics Program at the Memorial-Sloan Kettering Cancer Center (MSKCC) in New York. At the symposium, Dr Lowe shared important insights on cancer drivers and dependencies in primary liver cancers to a packed auditorium of participants ranging from students, clinicians and professors.
It is hoped that the symposium will initiate possible collaborations across different research and cancer centres in the near future and facilitiate closer co-operation among clinicians and scientists.